[go: up one dir, main page]

BR9917368A - Método para preparação de citalopram e preparação farmacêutica obtida - Google Patents

Método para preparação de citalopram e preparação farmacêutica obtida

Info

Publication number
BR9917368A
BR9917368A BR9917368-9A BR9917368A BR9917368A BR 9917368 A BR9917368 A BR 9917368A BR 9917368 A BR9917368 A BR 9917368A BR 9917368 A BR9917368 A BR 9917368A
Authority
BR
Brazil
Prior art keywords
preparation
citalopram
pharmaceutical
pharmaceutical preparation
palladium catalyst
Prior art date
Application number
BR9917368-9A
Other languages
English (en)
Other versions
BR9917368B1 (pt
Inventor
Hans Petersen
Michael Harold Rock
Henrik Svane
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR9917368A publication Critical patent/BR9917368A/pt
Publication of BR9917368B1 publication Critical patent/BR9917368B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)

Abstract

"MéTODO PARA PREPARAçãO DE CITALOPRAM E PREPARAçãO FARMACêUTICA OBTIDA". Método para a preparação de citalopram compreendendo reação de um composto de Fórmula IV onde R é halogênio ou CF~ 3~-(CF~ 2~)~ n~-SO~ 2~-, n sendo 0-8, com uma fonte de cianeto na presença de um catalisador de paládio e uma quantidade catalítica de Cu^ +^ ou Zn^ 2+^, ou com Zn(CN)~ 2~ na presença de um catalisador de paládio.
BRPI9917368-9A 1999-06-25 1999-11-22 mÉtodo para preparaÇço de citalopram. BR9917368B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900920 1999-06-25
DKPA199900920 1999-06-25
PCT/DK1999/000640 WO2000013648A2 (en) 1999-06-25 1999-11-22 Method for the preparation of citalopram

Publications (2)

Publication Number Publication Date
BR9917368A true BR9917368A (pt) 2002-03-05
BR9917368B1 BR9917368B1 (pt) 2010-02-09

Family

ID=8099035

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9917368-9A BR9917368B1 (pt) 1999-06-25 1999-11-22 mÉtodo para preparaÇço de citalopram.

Country Status (36)

Country Link
US (2) US20020077353A1 (pt)
EP (1) EP1159274B1 (pt)
JP (1) JP3447267B2 (pt)
KR (1) KR100491368B1 (pt)
CN (2) CN1140521C (pt)
AR (1) AR020863A1 (pt)
AT (3) AT409961B (pt)
AU (2) AU2001100440B4 (pt)
BG (1) BG65574B1 (pt)
BR (1) BR9917368B1 (pt)
CA (2) CA2290127C (pt)
CH (1) CH691305A5 (pt)
CZ (1) CZ292198B6 (pt)
DE (2) DE19983487C1 (pt)
DK (2) DK1159274T3 (pt)
EA (1) EA002560B1 (pt)
ES (2) ES2194545T3 (pt)
FI (1) FI108641B (pt)
GB (2) GB2354239B (pt)
HK (1) HK1049002B (pt)
HU (1) HUP0103235A3 (pt)
IL (2) IL145959A0 (pt)
IS (1) IS2343B (pt)
IT (1) ITMI991581A1 (pt)
MX (1) MXPA01010989A (pt)
NO (1) NO328542B1 (pt)
NZ (1) NZ514979A (pt)
PL (1) PL205579B1 (pt)
PT (1) PT1159274E (pt)
SE (1) SE516690C2 (pt)
SI (1) SI1159274T1 (pt)
SK (1) SK285813B6 (pt)
TR (1) TR200103702T2 (pt)
UA (1) UA63034C2 (pt)
WO (1) WO2000013648A2 (pt)
ZA (1) ZA200108854B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1140886B1 (en) 1998-12-23 2003-04-02 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
KR100604156B1 (ko) 1999-04-14 2006-07-25 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
HK1043129B (zh) 1999-10-25 2004-10-21 H‧隆德贝克有限公司 西酞普蘭的製備方法
EP1228056B1 (en) 1999-10-25 2004-09-22 H. Lundbeck A/S Method for the preparation of citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
CN1398263A (zh) 1999-12-28 2003-02-19 H·隆德贝克有限公司 制备西酞普兰的方法
HK1052512B (zh) 1999-12-30 2006-03-03 H. 隆德贝克有限公司 西酞普兰的制备方法
PL197821B1 (pl) 2000-01-14 2008-04-30 Lundbeck & Co As H Sposób wytwarzania 5-cyjanoftalidu
NL1017415C1 (nl) 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
TR200202166T2 (tr) 2000-03-13 2002-12-23 H. Lndbeck A/S Sitalopramın preparasyon metodu
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
NZ521204A (en) * 2000-03-13 2004-03-26 H Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)- 1,3-dihydroisobenzofurans for preparing citalopram, an anti depressant
PT1265882E (pt) 2000-03-14 2004-06-30 Lundbeck & Co As H Metodo para preparacao de citalopram; composto e citalopram
HUP0300134A2 (en) * 2000-03-16 2003-05-28 Lundbeck & Co As H Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
EA200200332A1 (ru) * 2000-07-06 2002-06-27 Х.Лундбекк А/С Способ получения циталопрама
IL144817A0 (en) * 2000-08-18 2002-06-30 Lundbeck & Co As H Method for the preparation of citalopram
IL147226A (en) * 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure citalopram
SK284418B6 (sk) * 2000-12-28 2005-04-01 H. Lundbeck A/S Spôsob výroby citalopramu
EP1355897A1 (en) 2001-01-30 2003-10-29 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
CZ20032567A3 (en) * 2001-03-09 2004-04-14 Ranbaxy Laboratories Limited Process for the preparation of citalopram
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
TWI306846B (en) 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
EP1797060A2 (en) 2004-08-23 2007-06-20 Sun Pharmaceutical Industries Limited "process for preparation of citalopram and enantiomers"
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram
CN114763343A (zh) * 2021-01-14 2022-07-19 浙江华海药业股份有限公司 一种西酞普兰或s-西酞普兰的纯化方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (pt) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DK213290D0 (da) * 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) * 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
SK283309B6 (sk) * 1997-07-08 2003-05-02 H. Lundbeck A/S Spôsob výroby citalopramu a medziprodukty
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
ES2149734T3 (es) * 1997-11-11 2003-02-16 Lundbeck & Co As H Metodo para la preparacion de citalopram.
WO2000023431A1 (en) * 1998-10-20 2000-04-27 H. Lundbeck A/S Method for the preparation of citalopram
EP1140886B1 (en) * 1998-12-23 2003-04-02 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) * 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
KR100604156B1 (ko) * 1999-04-14 2006-07-25 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
EP1228056B1 (en) * 1999-10-25 2004-09-22 H. Lundbeck A/S Method for the preparation of citalopram
AR026063A1 (es) * 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
NL1017415C1 (nl) * 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IL144817A0 (en) * 2000-08-18 2002-06-30 Lundbeck & Co As H Method for the preparation of citalopram
IL147226A (en) * 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure citalopram
SK284418B6 (sk) * 2000-12-28 2005-04-01 H. Lundbeck A/S Spôsob výroby citalopramu

Also Published As

Publication number Publication date
CA2290127A1 (en) 2000-12-25
AT4365U1 (de) 2001-06-25
BG106191A (en) 2002-08-30
PT1159274E (pt) 2003-08-29
AU1374500A (en) 2000-03-27
SE0100193L (sv) 2001-04-25
EA002560B1 (ru) 2002-06-27
SK285813B6 (sk) 2007-08-02
CN1367786A (zh) 2002-09-04
HK1049002B (zh) 2004-12-31
ITMI991581A0 (it) 1999-07-15
PL205579B1 (pl) 2010-05-31
UA63034C2 (en) 2004-01-15
AT409961B (de) 2002-12-27
AR020863A1 (es) 2002-05-29
ITMI991581A1 (it) 2001-01-15
GB2357761A (en) 2001-07-04
NO20010319L (no) 2001-02-23
WO2000013648A8 (en) 2000-05-11
IS5861A (is) 2001-02-23
IS2343B (is) 2008-02-15
EP1159274A2 (en) 2001-12-05
DE69906389D1 (de) 2003-04-30
DK1159274T3 (da) 2003-07-21
HUP0103235A3 (en) 2003-01-28
SK18402001A3 (sk) 2002-06-04
ZA200108854B (en) 2002-08-28
CN1502616A (zh) 2004-06-09
IL145959A0 (en) 2002-07-25
NO20010319D0 (no) 2001-01-19
ATA904199A (de) 2002-05-15
NO328542B1 (no) 2010-03-15
TR200103702T2 (tr) 2002-06-21
CA2290127C (en) 2005-01-25
SE0100193D0 (sv) 2001-01-24
JP2002526386A (ja) 2002-08-20
EP1159274B1 (en) 2003-03-26
DE19983487C1 (de) 2002-07-25
FI108641B (fi) 2002-02-28
JP3447267B2 (ja) 2003-09-16
BG65574B1 (bg) 2009-01-30
US20090088469A1 (en) 2009-04-02
DK200100060A (da) 2001-04-10
PL346237A1 (en) 2002-01-28
EA200101072A1 (ru) 2002-02-28
IL145959A (en) 2007-07-24
GB0105182D0 (en) 2001-04-18
WO2000013648A2 (en) 2000-03-16
HUP0103235A2 (hu) 2002-01-28
HK1049002A1 (en) 2003-04-25
ATE235478T1 (de) 2003-04-15
SE516690C2 (sv) 2002-02-12
MXPA01010989A (es) 2002-06-04
CH691305A5 (de) 2001-06-29
GB2354239B (en) 2001-06-06
GB2357761B (en) 2001-09-05
KR20020012204A (ko) 2002-02-15
WO2000013648B1 (en) 2001-03-15
AU2001100440A4 (en) 2001-11-01
ES2194545T3 (es) 2003-11-16
WO2000013648A3 (en) 2000-07-13
FI20010155L (fi) 2001-02-09
SI1159274T1 (en) 2003-10-31
AU2001100440B4 (en) 2002-01-24
CA2475401A1 (en) 2000-12-25
DE69906389T2 (de) 2003-10-30
GB2354239A (en) 2001-03-21
CN1140521C (zh) 2004-03-03
KR100491368B1 (ko) 2005-05-24
NZ514979A (en) 2004-01-30
GB0101504D0 (en) 2001-03-07
CZ2001320A3 (en) 2001-05-16
US20020077353A1 (en) 2002-06-20
CZ292198B6 (cs) 2003-08-13
ES2189699A1 (es) 2003-07-01
BR9917368B1 (pt) 2010-02-09

Similar Documents

Publication Publication Date Title
BR9917368A (pt) Método para preparação de citalopram e preparação farmacêutica obtida
BR0207984A (pt) Inibidores de metaloproteinase
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
BR0109188A (pt) Diarilaminas 5-amida substituìdas como inibidores de mex
EP1501507A4 (en) TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY
HRP20050516B1 (hr) N-alkil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
BR0214666A (pt) Derivados de acetileno tendo atividade antagonìstica de mglur5
CR6393A (es) Moduladores de ccr5
BRPI0410995A (pt) derivados de n-alquinil-2-(arilóxi substituìdo)alquiltioamida como fungicidas
SE9903594L (sv) Katjoniska polymerer för slamavvattning
ES2180335T3 (es) Ligandos y complejos para la hidrogenacion enantioselectiva.
UY31502A1 (es) Proceso mejorado para sintetizar 5-cyclopentyl-5-11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-5-ol usando tmeda
BR0111567A (pt) Ligandos do receptor de melanocortina
BR0111583A (pt) Sistema catalisador, uso do mesmo, e, processo para preparar poliolefinas
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
BRPI0508644A (pt) catalisador ácido sólido e método de utilizar o mesmo
BR0007864A (pt) Composto, e, uso de um composto
BRPI0416365A (pt) métodos para modificar amido ou derivados de amido, e para preparar amido altamente solúvel, e, uso de um reator
BR0011664A (pt) Método de aumentar o conteúdo de constituìntes flavonóides e substâncias fenólicas em plantas, uso de plantas e, composição preparada através deste método
BR0314230A (pt) Método para a conversão catalìtica de carbonato orgânico ao álcool correspondente, e, uso de um catalisador suportado de zinco
BR9908215A (pt) Derivados de ácidos hidroxâmico e carboxìlico
FR2794116B1 (fr) Zeolithe im-5 au phosphore, composition catalytique, sa preparation et son utilisation en craquage catalytique
BR0307903A (pt) derivados de arilsulfona
BR0213990A (pt) Derivados de piperazina tendo atividade antagonìstica de sst1
BR0016134A (pt) Compostos, catalisador para a polimerização de olefinas e processos a preparação de compostos e de um catalisador e para a polimerização de olefinas

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/02/2010, OBSERVADAS AS CONDICOES LEGAIS. NA FOLHA 104 ONDE SE LE: "...DE ACORDO COM QUALQUER A REIVINDICACAO 4...", LEIA-SE: "...DE ACORDO COM A REIVINDICACAO 4...".

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 12A E 13A ANUIDADES.

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2260 DE 29/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 12A E 13A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2607 DE 22-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.